[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370020-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370020-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proteasome-stress-activates-yaptaz-through-the-rap2-map4ks-lats12-pathway-and-its-therapeutic-implications-in-solid-tumors","Proteasome stress activates YAP/TAZ through the RAP2 - MAP4Ks - LATS1/2 pathway and its therapeutic implications in solid tumors","","Tumor cells rely heavily on proteasome-dependent protein turnover, yet proteasome inhibitors show limited effectiveness in solid tumors despite success in hematologic cancers. This study demonstrates that proteasome stress functions as an upstream regulator of the Hippo pathway: proteasome inhibition causes RAP2 ubiquitination and inactivation, disrupting RAP2–MAP4Ks–NF2–LATS1/2 signaling and activating YAP/TAZ. YAP/TAZ activation promotes survival and resistance to proteasome inhibitors, while blocking YAP/TAZ restores drug sensitivity and suppresses growth in diffuse-type gastric cancer. The work links proteostasis to Hippo control and supports combination therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteasome-stress-activates-yaptaz-through-the-rap2-map4ks-lats12-pathway-and-its-therapeutic-implications-in-solid-tumors/370020/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteasome-stress-activates-yaptaz-through-the-rap2-map4ks-lats12-pathway-and-its-therapeutic-implications-in-solid-tumors/370020.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does proteasome inhibition trigger Hippo pathway activation?","Question",{"text":63,"@type":64},"When the proteasome is inhibited, RAP2 is ubiquitinated and becomes inactive, which disrupts the RAP2–MAP4Ks–NF2–LATS1/2 signaling cascade and activates YAP/TAZ.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does YAP/TAZ play during proteasome stress in solid tumors?",{"text":68,"@type":64},"YAP/TAZ activation promotes cell survival and resistance to proteasome inhibitors, allowing solid tumor cells to withstand treatment.",{"name":70,"@type":61,"acceptedAnswer":71},"How can resistance to proteasome inhibitors be overcome?",{"text":72,"@type":64},"Blocking YAP/TAZ can overcome this resistance and restore sensitivity to proteasome inhibitors, including in diffuse-type gastric cancer models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370020,1790722764,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Proteasome stress activates YAP/TAZ through the RAP2–MAP4Ks–LATS1/2 pathway and its therapeutic implications in solid tumors  \nXin Wanga,1, Yuan Gua, b,1,2, Zhenxing Zhonga, Pengcheng Yua, Wenshuai Liub,c, Rui Zhua , Yu Wanga , Zhaocai Zhoud , Yihong Sunb,c,  \nXuefei Wangb,c,2, and Fa-Xing Yua,2 Affiliations are included on p. 11.  \nEdited by Moshe Oren, Weizmann Institute of Science, Rehovot, Israel; received July 1, 2025; accepted November 10, 2025  \nTumor cells heavily depend on proteasome-mediated protein turnover, making the proteasome an attractive therapeutic target. Clinically, proteasome inhibitors are effective against hematologic cancers but show limited success with solid tumors, and the reasons for this difference are not well understood. Activation of yes-associated protein (YAP)/ TAZ, the downstream effectors of the Hippo pathway, is a key mechanism behind drug resistance in cancers. Here, we demonstrate that proteasome stress acts as an upstream signal of the Hippo pathway in solid tumor cells. When the proteasome is inhibited, RAP2 undergoes ubiquitination and becomes inactive, which in turn disrupts the RAP2–MAP4Ks–NF2–LATS1/2 signaling pathway, leading to the activation of YAP/TAZ. YAP/TAZ activation promotes cell survival and resistance to proteasome inhibitors. Conversely, blocking YAP/TAZ can overcome this resistance and restore cancer cell sensitivity to these drugs. In diffuse-type gastric cancer—an aggressive solid tumor with a poor prognosis and limited treatment options—combined inhibition of the proteasome andYAP/TAZ effectively suppresses tumor growth. Therefore, this study identifies proteasome stress as an upstream signal of the Hippo pathway and provides a mechanistic basis for combination cancer therapy.  \nHippo pathway | YAP | proteasome | solid tumor | drug repurposing  \nThe Hippo signaling pathway controls organ size, tissue regeneration, and tumorigenesis (1–6). The core components of the Hippo pathway constitute a kinase network in which mammalian STE20-like kinases (MST1/2, Hippo kinases) and mitogen-activated protein kinase kinase kinase kinases (MAP4K1-7, Hippo-like kinases) phosphorylate and activate large tumor suppressor kinases (LATS1/2), while LATS1/2 subsequently phosphorylate and suppress the activity of yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ, also known as WWTR1). YAP and TAZ are homologous transcriptional cofactors often referred to collectively as YAP/TAZ. They are generally considered to possess overlapping functions and regulatory mechanisms. Meanwhile, accumulating evidence indicates that YAP and TAZ may exert distinct functions and are regulated by different upstream signals (7) . Phosphorylated YAP/TAZ is sequestered in the cytoplasm, preventing access to downstream target genes. However, when upstream kinases are inactivated, YAP/TAZ translocates into the nucleus and, by interacting with transcription factors such as TEA domain family members (TEADs), drives the expression of genes involved in cell proliferation, differentiation, and survival (1, 2, 8–10) .  \nAberrant activation of YAP/TAZ has been frequently observed in various solid tumors, including gastric, liver, breast, and colorectal cancers (11–13). Elevated nuclear localization of YAP/TAZ in tumors is often correlated with aggressive clinical features and poor prognosis (11, 13, 14). In support, the activation of YAP/TAZ in mice by selective knockout of upstream components of the Hippo pathway can drive atypical hyperplasia or tumor igenesis in affected organs (6, 11, 15, 16) . Based on these results, the Hippo signaling pathway is recognized as a critical regulator in tumorigenesis.  \nYAP/TAZ also mediates resistance to chemotherapy, targeted therapy, and immuno therapy, hence representing a target for overcoming drug resistance in cancer management (17–20) . For example, in gastric cancer, increased YAP expression has been linked to resistance to the anti-HER2 ","cbCaintUHSm20JK3","https://ap.wps.com/l/cbCaintUHSm20JK3","pdf",5369660,"English","# Significance\n## Abstract-level mechanism and therapeutic implication\n## Background: Hippo pathway control and YAP/TAZ function\n## YAP/TAZ in tumor aggressiveness and drug resistance","[{\"question\":\"How does proteasome inhibition trigger Hippo pathway activation?\",\"answer\":\"When the proteasome is inhibited, RAP2 is ubiquitinated and becomes inactive, which disrupts the RAP2–MAP4Ks–NF2–LATS1/2 signaling cascade and activates YAP/TAZ.\"},{\"question\":\"What role does YAP/TAZ play during proteasome stress in solid tumors?\",\"answer\":\"YAP/TAZ activation promotes cell survival and resistance to proteasome inhibitors, allowing solid tumor cells to withstand treatment.\"},{\"question\":\"How can resistance to proteasome inhibitors be overcome?\",\"answer\":\"Blocking YAP/TAZ can overcome this resistance and restore sensitivity to proteasome inhibitors, including in diffuse-type gastric cancer models.\"}]","Proteasome stress activates YAP/TAZ through the RAP2 - MAP4Ks - LATS1/2 pathway and its therapeutic implications in solid tumors | PDF",1790186271,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3763cbd884327dada96cb9928352a35.webp",983,1316,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6517940575be10be5524baa80d27fb0b.webp",982,1315,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce2c27e73a2cb790d54b62a8d61390b5.webp",981,1313,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45ef68849bd14ff3d9446b8cf11ffca8.webp",980,1312]